NLSP
Price
$2.27
Change
+$0.02 (+0.89%)
Updated
Jul 17, 02:52 PM (EDT)
Capitalization
11.04M
TPST
Price
$6.72
Change
+$0.05 (+0.75%)
Updated
Jul 17, 02:57 PM (EDT)
Capitalization
24.56M
21 days until earnings call
Interact to see
Advertisement

NLSP vs TPST

Header iconNLSP vs TPST Comparison
Open Charts NLSP vs TPSTBanner chart's image
Nls Pharmaceutics
Price$2.27
Change+$0.02 (+0.89%)
Volume$100
Capitalization11.04M
Tempest Therapeutics
Price$6.72
Change+$0.05 (+0.75%)
Volume$500
Capitalization24.56M
NLSP vs TPST Comparison Chart in %
Loading...
NLSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NLSP vs. TPST commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NLSP is a Hold and TPST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (NLSP: $2.25 vs. TPST: $6.67)
Brand notoriety: NLSP and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NLSP: 11% vs. TPST: 62%
Market capitalization -- NLSP: $11.04M vs. TPST: $24.56M
NLSP [@Biotechnology] is valued at $11.04M. TPST’s [@Biotechnology] market capitalization is $24.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $300.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NLSP’s FA Score shows that 0 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • NLSP’s FA Score: 0 green, 5 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, both NLSP and TPST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NLSP’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • NLSP’s TA Score: 4 bullish, 5 bearish.
  • TPST’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, NLSP is a better buy in the short-term than TPST.

Price Growth

NLSP (@Biotechnology) experienced а -1.10% price change this week, while TPST (@Biotechnology) price change was -11.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.15%. For the same industry, the average monthly price growth was +13.73%, and the average quarterly price growth was +38.28%.

Reported Earning Dates

NLSP is expected to report earnings on May 16, 2025.

TPST is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TPST($24.6M) has a higher market cap than NLSP($11M). NLSP YTD gains are higher at: 6.635 vs. TPST (-38.517). NLSP has higher annual earnings (EBITDA): -12.02M vs. TPST (-43.32M). NLSP has less debt than TPST: NLSP (1.63M) vs TPST (13.1M). NLSP (0) and TPST (0) have equivalent revenues.
NLSPTPSTNLSP / TPST
Capitalization11M24.6M45%
EBITDA-12.02M-43.32M28%
Gain YTD6.635-38.517-17%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A21.5M-
Total Debt1.63M13.1M12%
FUNDAMENTALS RATINGS
TPST: Fundamental Ratings
TPST
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
89
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NLSPTPST
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NLSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYRE16.200.89
+5.81%
Spyre Therapeutics
DEFT3.410.13
+3.96%
DEFI Technologies Inc
TRVG3.690.12
+3.36%
trivago NV
NCNO30.040.76
+2.60%
nCino
ALL195.623.19
+1.66%
Allstate Corp (The)

NLSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NLSP has been loosely correlated with GRI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NLSP jumps, then GRI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NLSP
1D Price
Change %
NLSP100%
+2.38%
GRI - NLSP
38%
Loosely correlated
+15.00%
MBIO - NLSP
26%
Poorly correlated
-7.53%
GOVX - NLSP
25%
Poorly correlated
+6.43%
TPST - NLSP
25%
Poorly correlated
-0.30%
COCP - NLSP
24%
Poorly correlated
-2.00%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
-0.30%
PHIO - TPST
49%
Loosely correlated
N/A
ABCZF - TPST
48%
Loosely correlated
N/A
RXRX - TPST
40%
Loosely correlated
+3.26%
ARCT - TPST
39%
Loosely correlated
-2.28%
MGTX - TPST
38%
Loosely correlated
+1.17%
More